|
US6387897B1
(en)
*
|
1998-06-30 |
2002-05-14 |
Neuromed Technologies, Inc. |
Preferentially substituted calcium channel blockers
|
|
US20040259866A1
(en)
*
|
1998-06-30 |
2004-12-23 |
Snutch Terrance P. |
Calcium channel blockers comprising two benzhydril moieties
|
|
US20060084660A1
(en)
*
|
1998-06-30 |
2006-04-20 |
Neuromed Technologies Inc. |
Calcium channel blockers comprising two benzhydril moieties
|
|
US7186726B2
(en)
*
|
1998-06-30 |
2007-03-06 |
Neuromed Pharmaceuticals Ltd. |
Preferentially substituted calcium channel blockers
|
|
US6951862B2
(en)
*
|
1998-06-30 |
2005-10-04 |
Neuromed Technologies, Inc. |
Calcium channel blockers comprising two benzhydril moieties
|
|
US6492375B2
(en)
|
1998-06-30 |
2002-12-10 |
Neuromed Technologies, Inc. |
Partially saturated calcium channel blockers
|
|
US6011035A
(en)
*
|
1998-06-30 |
2000-01-04 |
Neuromed Technologies Inc. |
Calcium channel blockers
|
|
US20040266784A1
(en)
*
|
1998-06-30 |
2004-12-30 |
Snutch Terrance P. |
Calcium channel inhibitors comprising benzhydril spaced from piperazine
|
|
WO2004089922A2
(en)
*
|
1998-06-30 |
2004-10-21 |
Neuromed Technologies, Inc. |
Calcium channel inhibitors comprising benzhydril spaced from piperazine
|
|
US6943168B2
(en)
*
|
1998-06-30 |
2005-09-13 |
Neuromed Technologies Inc. |
Calcium channel inhibitors comprising benzhydril spaced from piperazine
|
|
CA2397681C
(en)
*
|
1999-12-20 |
2011-03-15 |
Neuromed Technologies, Inc. |
Partially saturated calcium channel blockers
|
|
JP2004503588A
(ja)
*
|
2000-07-13 |
2004-02-05 |
ファルマシア・コーポレーション |
全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−２阻害薬および血管調節化合物
|
|
US7151102B2
(en)
*
|
2000-10-30 |
2006-12-19 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
AR035974A1
(es)
|
2001-05-18 |
2004-07-28 |
Astrazeneca Ab |
Derivados de diarilmetil piperazina, procesos para su preparacion, uso de estos derivados para la elaboracion de medicamentos y composicion farmaceutica
|
|
JP4337138B2
(ja)
|
2001-08-31 |
2009-09-30 |
味の素株式会社 |
新規ジアリールアルケン誘導体及び新規ジアリールアルカン誘導体
|
|
US20030199523A1
(en)
*
|
2002-02-28 |
2003-10-23 |
Snutch Terrance P. |
Heterocyclic calcium in channel blockers
|
|
US20040204404A1
(en)
*
|
2002-09-30 |
2004-10-14 |
Robert Zelle |
Human N-type calcium channel blockers
|
|
SE0203302D0
(sv)
*
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Compounds
|
|
SE0203303D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Compounds
|
|
WO2004072615A2
(en)
*
|
2003-02-11 |
2004-08-26 |
Scion Pharmaceuticals, Inc. |
Methods for identifying ion channel modulators
|
|
EP1611116A2
(en)
*
|
2003-04-08 |
2006-01-04 |
Neuromed Technologies, Inc. |
Calcium channel inhibitors comprising benzhydril spaced from piperazine
|
|
JP2006526000A
(ja)
*
|
2003-05-30 |
2006-11-16 |
ニューロームド テクノロジーズ、インク． |
Ｎ型カルシウムチャネル遮断薬としての３−アミノメチル−ピロリジン
|
|
US7365050B2
(en)
*
|
2003-08-08 |
2008-04-29 |
The Regents Of The University Of California |
Methods for modulating a drug-related effect or behavior
|
|
GB0320983D0
(en)
*
|
2003-09-08 |
2003-10-08 |
Biofocus Plc |
Compound libraries
|
|
US7507760B2
(en)
*
|
2004-01-22 |
2009-03-24 |
Neuromed Pharmaceuticals Ltd. |
N-type calcium channel blockers
|
|
US20050227999A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Neuromed Technologies Inc. |
Diarylamine derivatives as calcium channel blockers
|
|
KR20070044803A
(ko)
*
|
2004-04-09 |
2007-04-30 |
뉴로메드 파머큐티칼즈 리미티드 |
칼슘 채널 차단제로서 디아릴아민 유도체
|
|
MX2007001240A
(es)
|
2004-08-02 |
2007-03-23 |
Astrazeneca Ab |
Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
|
|
GB0419072D0
(en)
*
|
2004-08-26 |
2004-09-29 |
Kudos Pharm Ltd |
Phthalazinone derivatives
|
|
AU2005279600A1
(en)
*
|
2004-08-30 |
2006-03-09 |
Neuromed Pharmaceuticals Ltd. |
Urea derivatives as calcium channel blockers
|
|
RS51411B
(en)
*
|
2004-09-10 |
2011-02-28 |
Newron Pharmaceuticals S.P.A. |
USE (R) - (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDE AS SELECTIVE MODULATORS OF SODIUM AND / OR CALCIUM CHANNELS
|
|
TW200630337A
(en)
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
|
US7511077B2
(en)
*
|
2005-02-09 |
2009-03-31 |
Neuromed Pharmaceuticals Ltd. |
Diamine calcium channel blockers
|
|
WO2006105670A1
(en)
*
|
2005-04-08 |
2006-10-12 |
Neuromed Pharmaceuticals Ltd. |
Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
|
|
AU2006239937A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Chromane and chromene derivatives and uses thereof
|
|
WO2007041360A2
(en)
*
|
2005-09-30 |
2007-04-12 |
The Board Of Trustees Of The University Of Illinois |
Peptides and calcium regulation in mammalian cells
|
|
US8299211B2
(en)
*
|
2005-09-30 |
2012-10-30 |
The Board Of Trustees Of The University Of Illinois |
Peptides and regulation of calcium channels
|
|
WO2007071035A1
(en)
*
|
2005-12-19 |
2007-06-28 |
Neuromed Pharmaceuticals Ltd. |
Heterocyclic amide derivatives as calcium channel blockers
|
|
PT1963280E
(pt)
*
|
2005-12-22 |
2016-02-02 |
Newron Pharm Spa |
Derivados de 2-feniletilamino como cálcio e/ou moduladores do canal de sódio
|
|
US8247442B2
(en)
*
|
2006-03-29 |
2012-08-21 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use
|
|
US8791264B2
(en)
*
|
2006-04-13 |
2014-07-29 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use as blockers of calcium channels
|
|
WO2007118854A1
(en)
*
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and the use thereof
|
|
WO2007118323A1
(en)
*
|
2006-04-17 |
2007-10-25 |
Neuromed Pharmaceuticals Ltd. |
Isoxazole derivatives as calcium channel blockers
|
|
US8362021B2
(en)
*
|
2006-05-11 |
2013-01-29 |
Zalicus Pharmaceuticals Ltd. |
Method for increasing the bioavailability of benzhydryl piperazine containing compounds
|
|
WO2007137417A1
(en)
*
|
2006-05-26 |
2007-12-06 |
Neuromed Pharmaceuticals Ltd. |
Heterocyclic compounds as calcium channel blockers
|
|
JP5539717B2
(ja)
*
|
2006-07-14 |
2014-07-02 |
塩野義製薬株式会社 |
オキシム化合物およびその使用
|
|
EP2061780A4
(en)
*
|
2006-09-14 |
2010-12-22 |
Zalicus Pharmaceuticals Ltd |
DIARYLE PIPERIDINE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS
|
|
WO2008043183A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Neuromed Pharmaceuticals Ltd. |
Cyclopropyl-piperazine compounds as calcium channel blockers
|
|
TWI404716B
(zh)
*
|
2006-10-17 |
2013-08-11 |
Kudos Pharm Ltd |
酞嗪酮（ｐｈｔｈａｌａｚｉｎｏｎｅ）衍生物
|
|
US20080139578A1
(en)
*
|
2006-11-30 |
2008-06-12 |
Catherine Abbadie |
Substituted piperizines for the treatment of pain
|
|
US8399486B2
(en)
*
|
2007-04-09 |
2013-03-19 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use thereof
|
|
US20090012010A1
(en)
*
|
2007-05-18 |
2009-01-08 |
Neuromed Phramaceuticals Ltd. |
Amino acid derivatives as calcium channel blockers
|
|
ES2422603T3
(es)
*
|
2007-05-31 |
2013-09-12 |
Shionogi & Co |
Compuestos oxiimino y el uso de estos
|
|
NZ581288A
(en)
|
2007-06-15 |
2011-08-26 |
Newron Pharm Spa |
Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
|
|
WO2009040659A2
(en)
*
|
2007-09-28 |
2009-04-02 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
|
CA2700974A1
(en)
|
2007-10-04 |
2009-04-09 |
Merck Sharp & Dohme Corp. |
Substituted aryl sulfone derivatives as calcium channel blockers
|
|
AU2008313467B2
(en)
*
|
2007-10-17 |
2013-08-29 |
Kudos Pharmaceuticals Limited |
4- [3- (4-cyclopropanecarbonyl-piperazine-1-carbonyl) -4 -fluoro-benzyl] -2H-phthalazin-1-one
|
|
US20090270394A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Galemmo Jr Robert |
Cyclylamine derivatives as calcium channel blockers
|
|
US8518934B2
(en)
*
|
2008-06-11 |
2013-08-27 |
Shonogi & Co., Ltd. |
Oxycarbamoyl compounds and the use thereof
|
|
GB0812680D0
(en)
*
|
2008-07-10 |
2008-08-20 |
Sec Dep For Innovation Univers |
Fluid decontamination method and apparatus
|
|
EP2344450A1
(en)
*
|
2008-09-29 |
2011-07-20 |
Merck Sharp & Dohme Corp. |
Substituted aryl sulfone derivatives as calcium channel blockers
|
|
JP5524220B2
(ja)
|
2008-10-07 |
2014-06-18 |
アストラゼネカ・ユーケイ・リミテッド |
医薬配合物５１４
|
|
WO2011026240A1
(en)
|
2009-09-04 |
2011-03-10 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
|
WO2012027495A1
(en)
|
2010-08-27 |
2012-03-01 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
US8409560B2
(en)
|
2011-03-08 |
2013-04-02 |
Zalicus Pharmaceuticals Ltd. |
Solid dispersion formulations and methods of use thereof
|
|
CN103491964A
(zh)
|
2011-03-08 |
2014-01-01 |
扎里卡斯药品有限公司 |
固体分散体制剂及其使用方法
|
|
RS55240B1
(sr)
|
2011-06-27 |
2017-02-28 |
Newron Pharm Spa |
Fluorisani derivati arilalkilaminokarboksamida
|
|
WO2014134306A1
(en)
|
2013-03-01 |
2014-09-04 |
Zalicus Pharmaceuticals, Ltd. |
Heterocyclic inhibitors of the sodium channel
|
|
TR202021399A2
(tr)
*
|
2020-12-23 |
2021-01-21 |
Atatuerk Ueniversitesi Rektoerluegue Bilimsel Arastirma Projeleri Bap Koordinasyon Birimi |
Beni̇di̇pi̇ni̇n epi̇lepsi̇ hastaliğinin tedavi̇si̇ne yöneli̇k kullanimi
|
